Kadans Science Partner I BE
The computed 12-month bankruptcy probability of Kadans Science Partner I BE is 0.7% (low). The 2022 annual accounts show equity of €29.06M and a net result of €-315k. Its solvency ranks better than 76% of 1109 sector peers (fiscal year 2022). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €29.06M |
| Net result | €-315k |
| Better than sector | 76% |
| Active | 5 yrs |
Mixed profile: strong on stability, weaker on profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 57.0% | 16.3% | |
| Net result | €-315k | €962 | |
| Equity | €29.06M | €126k | |
| Gross operating margin | €-129k | €46k | |
| Total assets | €50.98M | €1.38M |
Show 9 other metrics
| Fiscal year | 2022 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €-136k |
| Net profit | €-315k |
| Cash flow | €-305k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €50.98M |
| Equity | €29.06M |
| Debt | €21.92M |
| of which ≤ 1y | €5.17M |
| of which > 1y | €16.75M |
| Working capital | €-4.74M |
| Employees (FTE) | - |
| 2022 | |
|---|---|
| Current ratio | 0.08 |
| Quick ratio | 0.08 |
| Working capital ratio | -9.3% |
| Solvency | 57.0% |
| Debt / equity | 0.75 |
| Long-term debt ratio | 0.58 |
| Interest coverage | -0.71 |
| Gross margin | - |
| Net margin | - |
| ROA | -0.6% |
| ROE | -1.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €50.98M |
| Fixed assets | 21/28 | €49.94M |
| Formation expenses | 20 | €607k |
| Financial fixed assets | 28 | €49.94M |
| Current assets | 29/58 | €433k |
| Amounts receivable within one year | 40/41 | €418k |
| Cash & bank | 54/58 | €15k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €50.98M |
| Equity | 10/15 | €29.06M |
| Contributions / capital | 10/11 | €30.00M |
| Accumulated profits (losses) | 14 | €-942k |
| Amounts payable | 17/49 | €21.92M |
| Amounts payable after one year | 17 | €16.75M |
| Amounts payable within one year | 42/48 | €5.17M |
| Trade debts payable within one year | 44 | €727k |
| Income statement | ||
| Gross operating margin | 9900 | €-129k |
| Operating result | 9901 | €-146k |
| Financial income | 75 | €22k |
| Financial charges | 65 | €192k |
| Result before taxes | 9903 | €-315k |
| Net result for the period | 9904 | €-315k |
| Result to be appropriated | 9905 | €-315k |
| NACE primary | Bemiddeling in verband met exploitatie van en handel in onroerend goed(68310) |
| Legal form | Limited partnership(612) |
| Incorporation | 29-07-2021 |
| Status | Active |
| Postal code | 1000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21805E0534/00D000 | Brussels | 1,027 m² | 1 · 800 m² | 44.0 m · 8 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Of the 11 Belgian State Gazette acts we know for this company, 1 has been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.
06-08-2026 General meeting · Permanent representative · Filing representative
- Publication: 06/08/2026 · Kadans Science Partner I BЕ
- Filing: 30/07/2026 · Kadans Science Partner I BЕ
- General meeting: 29/05/2026 · Kadans Science Partner I BЕ
- Permanent representative: replaces: e4, start_date: 29/05/2026 · Jeroen Bockaert
- Filing representative: scope: publiceren in de Bijlagen tot het Belgisch Staatsblad, met inbegrip van het opstellen en ondertekenen van de relevante publicatieformulieren · Christophe Tans
- Filing representative: scope: publiceren in de Bijlagen tot het Belgisch Staatsblad, met inbegrip van het opstellen en ondertekenen van de relevante publicatieformulieren · Irene Florescu
- Filing representative: scope: publiceren in de Bijlagen tot het Belgisch Staatsblad, met inbegrip van het opstellen en ondertekenen van de relevante publicatieformulieren · Madalina Dinu
Technical details
{
"facts": [
{
"date": "2026-08-06",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 06/08/2026",
"value": "06/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-30",
"type": "filing",
"quote": "neergelegd/ontvangen op 30 JULI 2026",
"value": "30/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-05-29",
"type": "general_meeting",
"quote": "Uittreksel van de notulen van de gewone algemene vergadering van vennoten dd 29 mei 2026",
"value": "29/05/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-05-29",
"type": "permanent_representative",
"quote": "zal vertegenwoordigd worden door Jeroen Bockaert, bedrijfsrevisor, in de uitoefening van zijn mandaat van commissaris ter vervanging van Didier Matriche, bedrijfsrevisor.",
"value": {
"replaces": "e4",
"start_date": "29/05/2026"
},
"object": "e2",
"subject": "e3"
},
{
"type": "filing_representative",
"quote": "verleent hierbij volmacht aan de heer Christophe Tans of mevrouw Irene Florescu of mevrouw Madalina Dinu, elk individueel bevoegd, om dit besluit te publiceren in de Bijlagen tot het Belgisch Staatsblad",
"value": {
"scope": "publiceren in de Bijlagen tot het Belgisch Staatsblad, met inbegrip van het opstellen en ondertekenen van de relevante publicatieformulieren"
},
"object": "e1",
"subject": "e5"
},
{
"type": "filing_representative",
"quote": "verleent hierbij volmacht aan de heer Christophe Tans of mevrouw Irene Florescu of mevrouw Madalina Dinu, elk individueel bevoegd, om dit besluit te publiceren in de Bijlagen tot het Belgisch Staatsblad",
"value": {
"scope": "publiceren in de Bijlagen tot het Belgisch Staatsblad, met inbegrip van het opstellen en ondertekenen van de relevante publicatieformulieren"
},
"object": "e1",
"subject": "e6"
},
{
"type": "filing_representative",
"quote": "verleent hierbij volmacht aan de heer Christophe Tans of mevrouw Irene Florescu of mevrouw Madalina Dinu, elk individueel bevoegd, om dit besluit te publiceren in de Bijlagen tot het Belgisch Staatsblad",
"value": {
"scope": "publiceren in de Bijlagen tot het Belgisch Staatsblad, met inbegrip van het opstellen en ondertekenen van de relevante publicatieformulieren"
},
"object": "e1",
"subject": "e7"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1833,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0771.824.149",
"kind": "company",
"name": "Kadans Science Partner I B\u0415",
"attrs": {
"seat": "Marnixlaan 23, 5\u00B0 verdieping, 1000 Brussel",
"legal_form": "Commanditaire vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "company",
"name": "PwC Bedrijfsrevisoren BV",
"attrs": {
"seat": "1831 Diegem, Culliganlaan 5"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Jeroen Bockaert",
"attrs": {
"rrn": "N.N.",
"address": null,
"birth_date": null,
"birth_place": null
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Didier Matriche",
"attrs": {
"rrn": "N.N.",
"address": null,
"birth_date": null,
"birth_place": null
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Christophe Tans",
"attrs": {
"rrn": "N.N.",
"address": null,
"birth_date": null,
"birth_place": null
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Irene Florescu",
"attrs": {
"rrn": "N.N.",
"address": null,
"birth_date": null,
"birth_place": null
}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Madalina Dinu",
"attrs": {
"rrn": "N.N.",
"address": null,
"birth_date": null,
"birth_place": null
}
}
]
}06-12-2024 2 directors appointed
- PwC Bedrijfsrevisoren BV, Commissaris
- Didier Matriche, Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": "1831 Diegem, Culliganlaan 5",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De algemene vergadering benoemt PwC Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als commissaris voor een termijn van drie jaar.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "3"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De algemene vergadering verleent hierbij volmacht aan Christophe TANS of lrene FLORESCU, elk individueel bevoegd, om dit besluit te publiceren in de Bijlagen tot het Belgisch Staatsblad, met inbegrip van het opstellen en ondertekenen van de relevante publicatieformulieren.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Didier Matriche",
"address": null,
"birth_date": null,
"profession": "bestuurder, bedrijfsrevisor",
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": "1831 Diegem, Culliganlaan 5",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Deze vennootschap wijst overeenkomstig artikel 3:60 WWV Didier Matriche, bestuurder, bedrijfsrevisor, aan als vaste vertegenwoordiger, voor de uitoefening van het mandaat.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-12-06",
"filing_date": "2024-11-28",
"act_kind_objet": "Herbenoeming commissaris"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-06-14",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0771.824.149",
"name_full": "Kadans Science Partner I BE",
"legal_form": "CV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Christophe Tans",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}25-09-2024 Capital increase of €16,100,000 to €46,100,000.65
- €30.000.000,65 → €46.100.000,65
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 46100000.65,
"delta_eur": 16100000.0,
"before_eur": 30000000.65,
"subscribers": [
{
"kbo": "0771.824.149",
"rrn": null,
"kind": "org",
"name": "Kadans Science Partner I BE",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 16100000,
"contribution_amount_eur": 16100000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 16100000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "schuldvordering_inbreng",
"paid_up_delta_eur": 16100000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Bernard Sacr\u00E9",
"firm_city": null,
"firm_name": null,
"office_city": "Elsene",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-09-25",
"filing_date": "2024-09-23",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-08-12",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-08-12"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.824.149",
"name_full": "Kadans Science Partner I BE",
"legal_form": "Commanditaire vennootschap",
"is_foreign_registered": true
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"volmachten",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}08-05-2024 Capital decrease of €615,256 to €30,000,000.65
- €30.615.256,65 → €30.000.000,65
Technical details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 30000000.65,
"delta_eur": -615256.0,
"before_eur": 30615256.65,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "agio_incorporation",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": 15427836,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
}
],
"notary": {
"name": "Vincent Vroninks",
"firm_city": null,
"firm_name": null,
"office_city": "Elsene",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-05-08",
"filing_date": "2024-05-06",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-01-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2023-12-29"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.824.149",
"name_full": "Kadans Science Partner I BE",
"legal_form": "Commanditaire vennootschap",
"is_foreign_registered": true
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"volmachten",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 30000016,
"class_name": "aandelen",
"capital_share_eur": 30000000.65,
"voting_rights_per_share": 1.0
}
]
}08-03-2023 Capital increase of €615,256.65 to €30,615,256.65
- €30.000.000 → €30.615.256,65
Technical details
{
"events": [
{
"kind": "fusion_share_issue",
"after_eur": 30615256.65,
"delta_eur": 615256.65,
"before_eur": 30000000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kadans Science Partner BE Services I",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 16,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kadans Science Partner I BE",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 15427836,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 15427852,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 15427852,
"merger_exchange_ratio": 16.2326,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Bernard Sacr\u00E9",
"firm_city": null,
"firm_name": null,
"office_city": "Elsene",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-03-08",
"filing_date": "2023-02-28",
"act_kind_objet": "MET FUSIE DOOR OVERNEMING GELIJKGESTELDE VERRICHTING-ALGEMENE VERGADERING VAN DE OVERNEMENDE VENNOOTSCHAP"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-01-30",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.824.149",
"name_full": "Kadans Science Partner I BE",
"legal_form": "Commanditaire Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"2 volmachten",
"bijlage speciale voorwaarden",
"brieven stedenbouw",
"de geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 45427852,
"class_name": "Gewone Aandelen",
"capital_share_eur": 30615256.65,
"voting_rights_per_share": 1.0
}
]
}| Legal nameNL | Kadans Science Partner I BE |